Eldec Pharmaceuticals
PrivateLast Round
Grant
Apr 21, 2026
Total Funding Raised
$6.26M
Company Overview
Eldec Pharmaceuticals operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Grant round in April 2026.
Eldec Pharmaceuticals is a biotechnology company that develops peptide-based therapies to treat chronic lung diseases and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eldec Pharmaceuticals Comparables
Compare Eldec Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biolytx Pharmaceuticals Corp. | 82% | |
| Aspiro Therapeutics | 81% | |
| Animate Biosciences | 80% |
For institutional investors. Book with your work email.
Eldec Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 21, 2026 | ||||
| Seed | Feb 9, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Accelerator | May 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eldec Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| North Carolina Biotechnology Center | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2018
Completed an Accelerator round of funding.
For institutional investors. Book with your work email.
Eldec Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eldec Pharmaceuticals's valuation, stock price, and market status.
Is Eldec Pharmaceuticals a public or private company?
Eldec Pharmaceuticals is a private company.
What is the current stock price of Eldec Pharmaceuticals?
Eldec Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Eldec Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eldec Pharmaceuticals worth (valuation)?
Valuation information for Eldec Pharmaceuticals is not publicly available.
Can I buy Eldec Pharmaceuticals stock?
Eldec Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eldec Pharmaceuticals's last funding round?
Eldec Pharmaceuticals's most recent funding round was Grant on April 21, 2026.
Who are the main investors in Eldec Pharmaceuticals?
Key investors in Eldec Pharmaceuticals include NIH RADx, North Carolina Biotechnology Center, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences.
Will Eldec Pharmaceuticals IPO soon?
No public IPO plans have been announced for Eldec Pharmaceuticals.
How can I track Eldec Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Eldec Pharmaceuticals's shares on secondary markets.